Photo Credit: IANS

IANSLive

New York, Oct 21 (IANS) In a major breakthrough, researchers including one of Indian-origin have found that tocilizumab drug reduced mortality by 30 per cent among critically ill Covid-19 patients when administered within the first two days of ICU admission.

To get full access of the story, click here to subscribe to IANS News Service

© 2020 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.

For news, views and gossips, follow IANS at Twitter.

Update: 21-October-2020